These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20849349)

  • 1. Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide.
    Qian Y; Wang F; Li R; Zhang Q; Xu Q
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1340-7. PubMed ID: 20849349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF; Maren TH
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
    Gupta S; Samanta MK
    Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methazolamide calcium phosphate nanoparticles in an ocular delivery system.
    Chen R; Qian Y; Li R; Zhang Q; Liu D; Wang M; Xu Q
    Yakugaku Zasshi; 2010 Mar; 130(3):419-24. PubMed ID: 20190526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of carbonic anhydrase inhibitors on aqueous humor chemistry and dynamics.
    Bar-Ilan A; Pessah NI; Maren TH
    Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1198-205. PubMed ID: 6434487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
    Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C
    Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experimental study on effect of methazolamide on decreasing intraocular pressure in rabbits].
    Xu H; Yao Q; Zhou G
    Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):55-7. PubMed ID: 11835778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide.
    Li R; Jiang S; Liu D; Bi X; Wang F; Zhang Q; Xu Q
    J Microencapsul; 2011; 28(2):134-41. PubMed ID: 21142697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
    Jansook P; Stefánsson E; Thorsteinsdóttir M; Sigurdsson BB; Kristjánsdóttir SS; Bas JF; Sigurdsson HH; Loftsson T
    Eur J Pharm Biopharm; 2010 Oct; 76(2):208-14. PubMed ID: 20637867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ocular distribution of methazolamide after corneal and scleral administration: the effect of ionization state.
    Conroy CW; Maren TH
    J Ocul Pharmacol Ther; 1998 Dec; 14(6):565-73. PubMed ID: 9867339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1330-9. PubMed ID: 20545523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of topically administered carbonic anhydrase inhibitors on aqueous humor dynamics in rabbits.
    Stein A; Pinke R; Krupin T; Glabb E; Podos SM; Serle J; Maren TH
    Am J Ophthalmol; 1983 Feb; 95(2):222-8. PubMed ID: 6824053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous Beagles.
    Gelatt KN; Gum G; Williams LW; Gwin RM
    Am J Vet Res; 1979 Mar; 40(3):334-45. PubMed ID: 475084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral administration of methazolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs.
    Skorobohach BJ; Ward DA; Hendrix DV
    Am J Vet Res; 2003 Feb; 64(2):183-7. PubMed ID: 12602587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of methazolamide in relation to the treatment of glaucoma.
    Maren TH; Haywood JR; Chapman SK; Zimmerman TJ
    Invest Ophthalmol Vis Sci; 1977 Aug; 16(8):730-42. PubMed ID: 407172
    [No Abstract]   [Full Text] [Related]  

  • 16. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
    Ma WD; Xu H; Nie SF; Pan WS
    Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
    Verma P; Gupta RN; Jha AK; Pandey R
    Drug Deliv; 2013; 20(7):269-76. PubMed ID: 24044644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetazolamide-like carbonic anhydrase inhibitors with topical ocular hypotensive activity.
    Antonaroli S; Bianco A; Brufani M; Cellai L; Lo Baido G; Potier E; Bonomi L; Perfetti S; Fiaschi AI; Segre G
    J Med Chem; 1992 Jul; 35(14):2697-703. PubMed ID: 1635066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system.
    Cao F; Zhang X; Ping Q
    Drug Deliv; 2010; 17(7):500-7. PubMed ID: 20500130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension.
    Gudmundsdóttir E; Stefánsson E; Bjarnadóttir G; Sigurjónsdóttir JF; Gudmundsdóttir G; Masson M; Loftsson T
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3552-4. PubMed ID: 11006251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.